BMC Public Health | |
Patient preferences and treatment safety for uncomplicated vulvovaginal candidiasis in primary health care | |
Study Protocol | |
Blanca Gutiérrez Teira1  Yolanda Hernando Sanz2  Paulino Cubero González3  Alicia Simón Fernández4  Beatriz López Uriarte5  Ana Rey López6  Fernanda Morales6  M del Canto De-Hoyos Alonso7  María J Rojas Giraldo8  Laura Balsalobre Arenas9  Dolores Martínez López9  Susana Tudanca Hernández9  Elisa Ceresuela Wiesmann1,10  Rosa A Escriva Ferrairo1,11  Jesús Fernández Horcajuelo1,12  Rocío A Vello Cuadrado1,12  Fernando Gallardo Alonso1,13  Jeannet Sánchez Yepes1,13  Yolanda Ginés Díaz1,14  Cristina De-Alba Romero1,15  Ana I González González1,16  M José Iglesias Piñeiro1,17  Carmen Carballo1,18  Francisca García-de-Blas González1,19  Ana Pastor Rodríguez-Moñino2,20  Jesús Martín Fernández2,21  Marta Sánchez-Celaya del Pozo2,22  Justo M Del-Alamo Rodríguez2,23  Teresa Sanz Cuesta2,24  Ricardo Rodríguez Barrientos2,25  Isabel Del-Cura González2,26  | |
[1] CS El Soto. Atención Primaria Area 8, Servicio Madrileño de Salud, Spain;CS Federica Montseny. Atención Primaria Area 9, Servicio Madrileño de Salud, Spain;CS General Ricardos. Atención Primaria Area 11, Servicio Madrileño de Salud, Spain;CS Huerta de los Frailes. Atención Primaria Area 9, Servicio Madrileño de Salud, Spain;CS Humanes. Atención Primaria Area 9, Servicio Madrileño de Salud, Spain;CS Jaime Vera. Atención Primaria Area 9, Servicio Madrileño de Salud, Spain;CS Laín Entralgo. Atención Primaria Area 8, Servicio Madrileño de Salud, Spain;CS Loranca. Atención Primaria Area 9, Servicio Madrileño de Salud, Spain;CS Mendiguchia. Atención Primaria Area 9, Servicio Madrileño de Salud, Spain;CS Palacio de Segovia. Atención Primaria Area 7, Servicio Madrileño de Salud, Spain;CS Palomares. Atención Primaria Area 9. Servicio Madrileño de Salud, Spain;CS Panaderas. Atención Primaria Area 9, Servicio Madrileño de Salud, Spain;CS Pedroches. Atención Primaria Area 9, Servicio Madrileño de Salud, Spain;CS Puerta Bonita. Atención Primaria Area 11, Servicio Madrileño de Salud, Spain;CS San Fermín. Atención Primaria Area 11, Servicio Madrileño de Salud, Spain;CS Vicente Muzas. Atención Primaria Area 9, Servicio Madrileño de Salud, Spain;CS Vicente Soldevilla. Atención Primaria Area 9, Servicio Madrileño de Salud, Spain;CS la Fortuna. Atención Primaria Area 9, Servicio Madrileño de Salud, Spain;CS. Mendiguchia. Atención Primaria Area 9. Servicio Madrileño de Salud, Spain;Departamento de Calidad. Atención Primaria Area 11, Servicio Madrileño de Salud, Spain;Departamento de Medicina de Familia, Atención Primaria Area 8. Servicio Madrileño de Salud, Spain;Departamento de Medicina de Familia. Atención Primaria Area 1, Servicio Madrileño de Salud, Spain;Servicio de Microbiología, Hospital Severo Ochoa. Leganés, Madrid, Spain;Técnico de Salud. Atención Primaria Area 9. Servicio Madrileño de Salud, Spain;Unidad de Investigación, Atención Primaria Area 5. Servicio Madrileño de Salud, Spain;Unidad de Investigación. Atención Primaria Area 9. Servicio Madrileño de Salud. Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Madrid, Spain; | |
关键词: Candidiasis; Family Physician; Candida Species; Vaginitis; Primary Health Care Service; | |
DOI : 10.1186/1471-2458-11-63 | |
received in 2010-10-12, accepted in 2011-01-31, 发布年份 2011 | |
来源: Springer | |
【 摘 要 】
BackgroundVaginitis is a common complaint in primary care. In uncomplicated candidal vaginitis, there are no differences in effectiveness between oral or vaginal treatment. Some studies describe that the preferred treatment is the oral one, but a Cochrane's review points out inconsistencies associated with the report of the preferred way that limit the use of such data. Risk factors associated with recurrent vulvovaginal candidiasis still remain controversial.Methods/DesignThis work describes a protocol of a multicentric prospective observational study with one year follow up, to describe the women's reasons and preferences to choose the way of administration (oral vs topical) in the treatment of not complicated candidal vaginitis. The number of women required is 765, they are chosen by consecutive sampling. All of whom are aged 16 and over with vaginal discharge and/or vaginal pruritus, diagnosed with not complicated vulvovaginitis in Primary Care in Madrid.The main outcome variable is the preferences of the patients in treatment choice; secondary outcome variables are time to symptoms relief and adverse reactions and the frequency of recurrent vulvovaginitis and the risk factors. In the statistical analysis, for the main objective will be descriptive for each of the variables, bivariant analysis and multivariate analysis (logistic regression).. The dependent variable being the type of treatment chosen (oral or topical) and the independent, the variables that after bivariant analysis, have been associated to the treatment preference.DiscussionClinical decisions, recommendations, and practice guidelines must not only attend to the best available evidence, but also to the values and preferences of the informed patient.
【 授权许可】
CC BY
© Del-Cura González et al; licensee BioMed Central Ltd. 2011
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202311090022724ZK.pdf | 313KB | download |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]
- [37]
- [38]